Symbols / BDMD $2.30 -4.17%
BDMD Chart
About
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; long microwave ablation needles; and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, as well as soft tissue ablation. It sells its products through third-party distributors. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 84.47M |
| Enterprise Value | 81.16M | Income | -3.17M | Sales | 31.86M |
| Book/sh | 1.34 | Cash/sh | 0.09 | Dividend Yield | — |
| Payout | 0.00% | Employees | 143 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 2.65 | P/B | 1.72 | P/C | — |
| EV/EBITDA | 88.28 | EV/Sales | 2.55 | Quick Ratio | 1.22 |
| Current Ratio | 1.71 | Debt/Eq | 63.33 | LT Debt/Eq | — |
| EPS (ttm) | -0.11 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | -39.40% | Earnings | — | ROA | -0.20% |
| ROE | -8.03% | ROIC | — | Gross Margin | 86.94% |
| Oper. Margin | -131.30% | Profit Margin | -9.95% | Shs Outstand | 36.73M |
| Shs Float | 7.72M | Short Float | 6.41% | Short Ratio | 0.21 |
| Short Interest | — | 52W High | 7.26 | 52W Low | 0.76 |
| Beta | -1.42 | Avg Volume | 2.04M | Volume | 683.83K |
| Target Price | — | Recom | None | Prev Close | $2.40 |
| Price | $2.30 | Change | -4.17% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$2.30
Latest analyst target
3. DCF / Fair value
$1.23
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.30
Low
—
High
—
Mean
—
- Argentina clears minimally invasive ablation tech from Baird Medical - Stock Titan hu, 12 Mar 2026 12
- BDMD Stock Price, Quote & Chart | BAIRD MEDICAL INVESTMENT HOL (NASDAQ:BDMD) - ChartMill Fri, 13 Mar 2026 07
- Baird Medical Investment (NASDAQ:BDMD) Upgraded to Hold at Wall Street Zen - MarketBeat Sat, 14 Mar 2026 06
- Baird Medical Investment Holdings Limited (NASDAQ:BDMD) Stock's 28% Dive Might Signal An Opportunity But It Requires Some Scrutiny - simplywall.st ue, 07 Oct 2025 07
- Declining Stock and Solid Fundamentals: Is The Market Wrong About Baird Medical Investment Holdings Limited (NASDAQ:BDMD)? - Yahoo Finance Wed, 01 Oct 2025 07
- BDMD Stock Surges Amid Strategic Moves and Market Dynamics - StocksToTrade Fri, 20 Feb 2026 08
- Less-invasive thyroid treatment gains ground with Baird Medical in U.S. - Stock Titan Wed, 25 Feb 2026 08
- Baird Medical Investment Holdings Limited (NASDAQ:BDMD) Short Interest Update - MarketBeat ue, 10 Mar 2026 23
- Baird Medical Investment Holdings Ltd. Receives Regulatory Clearance for Microwave Ablation Systems in Argentina - marketscreener.com hu, 12 Mar 2026 12
- BDMD Stock Rises on Strategic Expansion Moves - StocksToTrade Fri, 20 Feb 2026 08
- Could The Market Be Wrong About Baird Medical Investment Holdings Limited (NASDAQ:BDMD) Given Its Attractive Financial Prospects? - simplywall.st Sat, 27 Sep 2025 07
- In Miami, Baird Medical shows doctors minimally invasive endocrine tools - Stock Titan Mon, 02 Mar 2026 08
- Short Interest in Baird Medical Investment Holdings Limited (NASDAQ:BDMD) Grows By 23.5% - MarketBeat ue, 03 Mar 2026 08
- Minimally invasive thyroid ablation highlighted at NASIT 2026 - Stock Titan Mon, 09 Mar 2026 12
- AI maps surgeons' moves: Baird Medical readies software for US, EU, China - Stock Titan Wed, 04 Mar 2026 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.11 | 0.14 | 0.12 | 0.19 |
| NormalizedEBITDA | 16.17M | 14.03M | 16.29M | 14.16M |
| NetIncomeFromContinuingOperationNetMinorityInterest | 12.45M | 10.55M | 12.57M | 10.09M |
| ReconciledDepreciation | 1.51M | 1.38M | 1.47M | 1.40M |
| ReconciledCostOfRevenue | 4.38M | 4.23M | 7.05M | 4.54M |
| EBITDA | 16.17M | 14.03M | 16.29M | 14.16M |
| EBIT | 14.66M | 12.65M | 14.82M | 12.76M |
| NetInterestIncome | -576.36K | -284.27K | -290.72K | -151.59K |
| InterestExpense | 576.75K | 285.83K | 299.27K | 153.92K |
| InterestIncome | 393.00 | 1.56K | 8.55K | 2.33K |
| NormalizedIncome | 12.45M | 10.55M | 12.57M | 10.09M |
| NetIncomeFromContinuingAndDiscontinuedOperation | 12.45M | 10.55M | 12.57M | 10.09M |
| TotalExpenses | 21.72M | 18.80M | 20.08M | 14.63M |
| TotalOperatingIncomeAsReported | 15.32M | 11.86M | 13.63M | 11.92M |
| DilutedAverageShares | 25.63M | 25.56M | 25.56M | 25.56M |
| BasicAverageShares | 25.56M | 25.56M | 25.56M | 25.56M |
| DilutedEPS | 0.49 | 0.41 | 0.49 | 0.39 |
| BasicEPS | 0.49 | 0.41 | 0.49 | 0.39 |
| DilutedNIAvailtoComStockholders | 12.50M | 10.55M | 12.57M | 10.09M |
| AverageDilutionEarnings | 50.75K | 0.00 | 0.00 | |
| NetIncomeCommonStockholders | 12.45M | 10.55M | 12.57M | 10.09M |
| NetIncome | 12.45M | 10.55M | 12.57M | 10.09M |
| MinorityInterests | -144.73K | -112.20K | -206.22K | -93.97K |
| NetIncomeIncludingNoncontrollingInterests | 12.60M | 10.66M | 12.77M | 10.18M |
| NetIncomeContinuousOperations | 12.60M | 10.66M | 12.77M | 10.18M |
| TaxProvision | 1.49M | 1.70M | 1.75M | 2.42M |
| PretaxIncome | 14.09M | 12.36M | 14.52M | 12.61M |
| OtherIncomeExpense | -651.66K | -10.21K | -194.58K | -335.07K |
| OtherNonOperatingIncomeExpenses | -651.66K | -10.21K | -194.58K | -335.07K |
| NetNonOperatingInterestIncomeExpense | -576.36K | -284.27K | -290.72K | -151.59K |
| InterestExpenseNonOperating | 576.75K | 285.83K | 299.27K | 153.92K |
| InterestIncomeNonOperating | 393.00 | 1.56K | 8.55K | 2.33K |
| OperatingIncome | 15.32M | 12.65M | 15.01M | 13.09M |
| OperatingExpense | 17.34M | 14.58M | 13.03M | 10.09M |
| OtherOperatingExpenses | -266.00 | -791.96K | -1.38M | -1.18M |
| ProvisionForDoubtfulAccounts | 1.20M | 2.20M | 400.00K | |
| ResearchAndDevelopment | 6.17M | 4.27M | 3.86M | 1.04M |
| SellingGeneralAndAdministration | 9.96M | 8.89M | 10.15M | 10.22M |
| SellingAndMarketingExpense | 4.06M | 2.55M | 3.59M | 3.57M |
| GeneralAndAdministrativeExpense | 5.90M | 6.35M | 6.56M | 6.65M |
| OtherGandA | 5.90M | 6.35M | 6.56M | 6.65M |
| GrossProfit | 32.65M | 27.23M | 28.04M | 23.18M |
| CostOfRevenue | 4.38M | 4.23M | 7.05M | 4.54M |
| TotalRevenue | 37.04M | 31.46M | 35.09M | 27.72M |
| OperatingRevenue | 37.04M | 31.46M | 35.09M | 27.72M |
| Line Item | 2024-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 10.17M | |||
| OrdinarySharesNumber | 25.56M | 25.56M | 35.45M | 35.45M |
| ShareIssued | 35.73M | 25.56M | 35.45M | 35.45M |
| NetDebt | 17.51M | 9.09M | 4.52M | |
| TotalDebt | 20.88M | 11.51M | 7.44M | 2.93M |
| TangibleBookValue | 39.58M | 35.67M | 25.82M | 15.25M |
| InvestedCapital | 60.14M | 46.35M | 32.17M | 17.42M |
| WorkingCapital | 26.79M | 21.11M | 17.74M | 11.69M |
| NetTangibleAssets | 39.58M | 35.67M | 25.82M | 15.25M |
| CapitalLeaseObligations | 401.00K | 916.01K | 1.21M | 894.57K |
| CommonStockEquity | 39.66M | 35.75M | 25.93M | 15.38M |
| PreferredStockEquity | 29.00 | |||
| TotalCapitalization | 43.10M | 37.36M | 25.93M | 15.38M |
| TotalEquityGrossMinorityInterest | 39.76M | 35.71M | 25.78M | 15.02M |
| MinorityInterest | 101.34K | -43.39K | -155.59K | -353.41K |
| StockholdersEquity | 39.66M | 35.75M | 25.93M | 15.38M |
| GainsLossesNotAffectingRetainedEarnings | 1.45M | 2.50M | 3.12M | 3.31M |
| OtherEquityAdjustments | 1.45M | 2.50M | 3.12M | 3.31M |
| RetainedEarnings | 26.76M | 14.39M | 3.96M | -6.78M |
| AdditionalPaidInCapital | 11.44M | 18.85M | 18.85M | 18.85M |
| CapitalStock | 2.58K | 2.56K | 2.94K | 1.00 |
| CommonStock | 2.56K | 2.56K | 2.94K | 1.00 |
| PreferredStock | 29.00 | 0.00 | ||
| TotalLiabilitiesNetMinorityInterest | 38.20M | 21.00M | 16.84M | 10.26M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 3.58M | 2.03M | 816.88K | 494.12K |
| LongTermDebtAndCapitalLeaseObligation | 3.58M | 2.03M | 816.88K | 494.12K |
| LongTermCapitalLeaseObligation | 136.68K | 412.12K | 816.88K | 494.12K |
| LongTermDebt | 3.44M | 1.61M | ||
| CurrentLiabilities | 34.62M | 18.98M | 16.02M | 9.77M |
| CurrentDeferredLiabilities | 837.34K | 593.29K | 712.83K | 731.43K |
| CurrentDeferredRevenue | 792.10K | 499.90K | 692.51K | 701.53K |
| CurrentDeferredTaxesLiabilities | 45.24K | 93.39K | 20.32K | 29.91K |
| CurrentDebtAndCapitalLeaseObligation | 17.30M | 9.49M | 6.62M | 2.44M |
| CurrentCapitalLeaseObligation | 264.32K | 503.89K | 389.63K | 400.44K |
| CurrentDebt | 17.03M | 8.98M | 6.23M | 2.04M |
| OtherCurrentBorrowings | 867.77K | 817.49K | ||
| LineOfCredit | 16.17M | 8.17M | 6.23M | 2.04M |
| PayablesAndAccruedExpenses | 16.49M | 8.89M | 8.69M | 6.59M |
| CurrentAccruedExpenses | 2.52M | 864.69K | 104.95K | 158.04K |
| Payables | 13.97M | 8.03M | 8.58M | 6.44M |
| OtherPayable | 6.14M | 2.92M | 2.55M | 1.30M |
| DuetoRelatedPartiesCurrent | 3.70M | 3.79M | 4.02M | 4.06M |
| TotalTaxPayable | 2.87M | 770.95K | 1.80M | 739.40K |
| IncomeTaxPayable | 79.17K | 448.23K | 714.47K | 297.68K |
| AccountsPayable | 1.25M | 550.19K | 215.86K | 340.21K |
| TotalAssets | 77.96M | 56.71M | 42.62M | 25.28M |
| TotalNonCurrentAssets | 16.55M | 16.63M | 8.85M | 3.83M |
| OtherNonCurrentAssets | 121.51K | 152.45K | 45.95K | 80.14K |
| NonCurrentPrepaidAssets | 8.02M | 7.70M | 5.76M | 218.09K |
| NonCurrentDeferredAssets | 714.46K | 1.69M | 206.22K | 79.78K |
| NonCurrentDeferredTaxesAssets | 714.46K | 814.37K | 206.22K | 79.78K |
| GoodwillAndOtherIntangibleAssets | 74.30K | 84.85K | 110.62K | 128.94K |
| OtherIntangibleAssets | 16.53K | 25.48K | 49.48K | 62.77K |
| Goodwill | 57.77K | 59.38K | 61.14K | 66.17K |
| NetPPE | 7.62M | 7.00M | 2.73M | 3.33M |
| AccumulatedDepreciation | -4.59M | -3.58M | -2.66M | -2.01M |
| GrossPPE | 12.21M | 10.58M | 5.39M | 5.33M |
| Leases | 4.33M | 4.66M | 2.61M | 2.82M |
| OtherProperties | 807.08K | 1.20M | 1.62M | 1.32M |
| MachineryFurnitureEquipment | 7.08M | 4.72M | 1.16M | 1.19M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 61.42M | 40.08M | 33.76M | 21.45M |
| OtherCurrentAssets | 295.75K | 120.48K | 197.00K | 304.29K |
| PrepaidAssets | 10.27M | 5.81M | 5.80M | 3.25M |
| Inventory | 1.30M | 1.14M | 1.29M | 3.06M |
| FinishedGoods | 717.31K | 312.87K | 477.35K | 2.15M |
| WorkInProcess | 230.35K | 313.35K | 330.75K | 399.76K |
| RawMaterials | 348.91K | 516.35K | 485.15K | 507.56K |
| Receivables | 46.58M | 31.49M | 24.76M | 11.81M |
| DuefromRelatedPartiesCurrent | 2.86K | 394.58K | 391.72K | 79.26K |
| TaxesReceivable | 0.00 | 556.80K | ||
| AccountsReceivable | 46.58M | 31.10M | 24.37M | 11.17M |
| AllowanceForDoubtfulAccountsReceivable | -3.99M | -2.84M | -644.67K | -234.19K |
| GrossAccountsReceivable | 50.57M | 33.94M | 25.02M | 11.41M |
| CashCashEquivalentsAndShortTermInvestments | 2.97M | 1.51M | 1.71M | 3.03M |
| CashAndCashEquivalents | 2.97M | 1.51M | 1.71M | 3.03M |
| CashFinancial | 2.97M | 1.51M | 1.71M | 3.03M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -9.17M | -3.66M | -5.47M | 3.87M |
| RepaymentOfDebt | -11.79M | -7.68M | -4.61M | -3.65M |
| IssuanceOfDebt | 22.10M | 12.15M | 9.07M | 3.57M |
| IssuanceOfCapitalStock | 2.90M | 0.00 | 0.00 | |
| CapitalExpenditure | -2.85M | -2.64M | -5.95M | -1.39M |
| InterestPaidSupplementalData | 497.25K | 261.32K | 243.84K | 90.08K |
| IncomeTaxPaidSupplementalData | 1.84M | 2.64M | 1.44M | 3.91M |
| EndCashPosition | 2.97M | 1.51M | 1.71M | 3.03M |
| BeginningCashPosition | 1.51M | 1.71M | 3.03M | 1.07M |
| EffectOfExchangeRateChanges | -94.27K | -3.11K | -297.65K | 18.55K |
| ChangesInCash | 1.55M | -197.33K | -1.02M | 1.94M |
| FinancingCashFlow | 10.72M | 3.46M | 4.41M | -1.93M |
| CashFlowFromContinuingFinancingActivities | 10.72M | 3.46M | 4.41M | -1.93M |
| NetOtherFinancingCharges | -2.49M | -1.01M | -46.40K | 3.59M |
| CashDividendsPaid | 0.00 | -5.43M | ||
| CommonStockDividendPaid | 0.00 | -5.43M | ||
| NetCommonStockIssuance | 2.90M | 0.00 | 0.00 | |
| CommonStockIssuance | 2.90M | 0.00 | 0.00 | |
| NetIssuancePaymentsOfDebt | 10.31M | 4.47M | 4.46M | -88.58K |
| NetShortTermDebtIssuance | 8.34M | 2.12M | 4.46M | 620.08K |
| ShortTermDebtPayments | -10.98M | -7.48M | -4.61M | -2.95M |
| ShortTermDebtIssuance | 19.32M | 9.60M | 9.07M | 3.57M |
| NetLongTermDebtIssuance | 1.97M | 2.35M | 0.00 | -708.66K |
| LongTermDebtPayments | -806.76K | -194.04K | 0.00 | -708.66K |
| LongTermDebtIssuance | 2.78M | 2.55M | 0.00 | |
| InvestingCashFlow | -2.85M | -2.64M | -5.92M | -1.39M |
| CashFlowFromContinuingInvestingActivities | -2.85M | -2.64M | -5.92M | -1.39M |
| NetIntangiblesPurchaseAndSale | 0.00 | 0.00 | -44.82K | 0.00 |
| PurchaseOfIntangibles | 0.00 | 0.00 | -44.82K | 0.00 |
| NetPPEPurchaseAndSale | -2.85M | -2.64M | -5.88M | -1.39M |
| SaleOfPPE | 0.00 | 0.00 | 32.66K | 561.00 |
| PurchaseOfPPE | -2.85M | -2.64M | -5.91M | -1.39M |
| OperatingCashFlow | -6.31M | -1.02M | 485.97K | 5.26M |
| CashFlowFromContinuingOperatingActivities | -6.31M | -1.02M | 485.97K | 5.26M |
| ChangeInWorkingCapital | -21.70M | -14.86M | -14.05M | -6.57M |
| ChangeInOtherWorkingCapital | 310.15K | -173.10K | 45.45K | -95.91K |
| ChangeInOtherCurrentLiabilities | -497.45K | -253.60K | 389.48K | -736.31K |
| ChangeInOtherCurrentAssets | 0.00 | -9.10K | -881.43K | -145.89K |
| ChangeInPayablesAndAccruedExpense | 1.31M | 582.95K | 2.38M | 624.37K |
| ChangeInAccruedExpense | -1.57M | 1.21M | 1.34M | 464.12K |
| ChangeInPayable | 2.88M | -630.94K | 1.04M | 160.25K |
| ChangeInAccountPayable | 727.80K | 341.52K | -100.93K | 274.31K |
| ChangeInTaxPayable | 2.15M | -972.47K | 1.14M | -114.06K |
| ChangeInIncomeTaxPayable | 2.15M | -972.47K | 1.14M | -114.06K |
| ChangeInPrepaidAssets | -4.84M | -5.44M | -3.45M | -525.78K |
| ChangeInInventory | -187.54K | 113.66K | 1.57M | -2.20M |
| ChangeInReceivables | -17.80M | -9.67M | -14.10M | -3.49M |
| ChangesInAccountReceivables | -17.80M | -9.67M | -14.84M | -2.94M |
| ProvisionandWriteOffofAssets | 1.25M | 2.34M | 439.00K | 231.35K |
| DeferredTax | 32.77K | -541.99K | -143.32K | -45.38K |
| DeferredIncomeTax | 32.77K | -541.99K | -143.32K | -45.38K |
| DepreciationAmortizationDepletion | 1.51M | 1.38M | 1.47M | 1.40M |
| DepreciationAndAmortization | 1.51M | 1.38M | 1.47M | 1.40M |
| Depreciation | 1.51M | 1.38M | 1.47M | 1.40M |
| OperatingGainsLosses | -5.42K | 54.70K | ||
| GainLossOnSaleOfPPE | 0.00 | 0.00 | -5.42K | 54.70K |
| NetIncomeFromContinuingOperations | 12.60M | 10.66M | 12.77M | 10.18M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for BDMD
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|